intellectual
property rights; the Company's success in integrating its acquisition's
operations into its own operations and the costs associated with
maintaining and/or developing two product suites; and general economic
conditions such as the rate of employment, inflation, interest rates and
the condition of capital markets. This list of factors is not
all-inclusive. In addition, the Company's success depends on the outcome of
various strategic initiatives it has undertaken, all of which are based on
assumptions made by the Company concerning trends in the clinical research
market and the health care industry. The Company undertakes no obligation
to update publicly or revise any forward-looking statement whether as a
result of new information, future events or otherwise.
DATATRAK International, Inc. and Subsidiaries
Condensed Consolidated Balance Sheet Data
(Unaudited)
March 31, December 31,
2008 2007
Cash and investments $5,950,860 $8,514,361
Accounts receivable, net 1,395,989 1,070,688
Property & equipment, net 3,214,069 3,534,799
Deferred tax assets 1,301,700 1,399,000
Intangible assets, net 333,808 520,458
Goodwill 10,856,113 10,856,113
Other 511,102 577,792
Total assets $23,563,641 $26,473,211
Accounts payable and other current
liabilities $6,452,693 $3,971,883
Long-term liabilities 2,674,241 5,931,962
Shareholders' equity
'/>"/>
SOURCE DATATRAK International, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 Related medicine technology :1.
DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects2.
DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.03.
Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study4.
Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research5.
New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting6.
International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet7.
UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation8.
Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment9.
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility10.
Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus11.
XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis